The global increase in the prevalence of dementia and its associated comorbidities and consequences has stimulated intensive research focused on better understanding of the basic mechanisms and the possibilities to prevent and/or treat cognitive decline or dementia. The etiology of cognitive decline and dementia is very complex and is based upon the interplay of genetic and environmental factors. A growing body of epidemiological evidence has suggested that metabolic syndrome and its components may be important in the development of cognitive decline. Furthermore, an abnormal body mass index in middle age has been considered as a predictor for the development of dementia. The Nutrition and Dementia Project (NutrDem Project) was started at the Department of Old Age Psychiatry and Psychotic Disorders with close cooperation with Department of Medical Psychology. The aim of this study is to determine the effect of dietary patterns, nutritional status, body composition (with evaluation of visceral fat) and basic regulatory mechanisms of metabolism in elderly patients on cognitive functions and the risk of cognitive impairment (mild cognitive impairment and/or dementia). (2014) 68, 1200-1203; doi:10.1038/ejcn.2014.171; published online 20 August 2014
INTRODUCTION
The global increase in the prevalence of dementia and its associated comorbidities and consequences has stimulated intensive research focused on better understanding of the basic mechanisms and the possibilities to prevent and/or treat cognitive decline or dementia. Despite the immensity of knowledge, the mechanisms responsible for the process of neurodegeneration are still insufficiently understood. In this context it is really difficult to talk about the prevention of dementia and cognitive decline. For the same reason, efforts towards developing effective treatments for neurodegenerative disorders have shown limited efficacy at best, with no true cure to this day being present. The etiology of cognitive decline and dementia is very complex and is based on the interplay of genetic and environmental factors. Genetic factors are resonsible for o 5% of Alzheimer's disease (AD) cases. Moreover, the associations between neuropathology and cognition are still not entirely clear. In addition, as pointed by Solomon et al., 1 the risk factors for AD dementia and the neuropathological hallmarks of AD may not necessarily be the same. In this context, identification, understanding and management of the mechanisms that link other risk factors to neuropathological processes is necessary. Recent work, both clinical and experimental, indicates that many neurodegenerative disorders often display a coexisting metabolic dysfunction, which may exacerbate cognitive decline. Moreover, it has been suggested that metabolic disturbances represent an important risk factor for the development of cognitive decline.
NUTRITIONAL STATUS AND RISK OF COGNITIVE DECLINE
Frisardi et al. 2 stated that a growing body of epidemiological evidence has suggested that metabolic syndrome and its components such as impaired glucose tolerance, abdominal or central obesity, hypertension, hypertriglyceridaemia and reduced high-density lipoprotein cholesterol may be important in the development of cognitive decline. It was proven that modifiable vascular and lifestyle-related factors were linked to the increased risk of dementia in late life. Recent data have suggested metabolic syndrome as an independent risk factor for Alzheimer's disease. 2 Some authors designed AD as a brain diabetes or diabetes 3.
3
There is a lot of evidence on the relationship between high body mass index (BMI) score and risk of dementia or cognitive decline. [4] [5] [6] [7] Furthermore, a high BMI in middle age or a decrease in BMI at late age has been considered a predictor for the development of AD. Based on their meta-analysis of papers on the relationship between BMI and dementia risk, Anstey et al. concluded that underweight, overweight and obesity in midlife increase dementia risk. 8 It is an open question if the association between BMI and cognitive decline could be explained by BMI-related brain atrophy. The relationship between BMI and brain volume in healthy adults was studied in several papers. An association between brain volume and degree of overweight was found. Gunstad et al.
14 found in a group of 201 healthy individuals (aged 17-79) in normal weight, overweight and obese groups that obese individuals showed smaller whole brain and total gray matter volume than normal weight and overweight individuals. They concluded that there is an independent relationship between BMI and brain structure and that these differences are not limited to older adults. Moreover, overweight has been associated with cerebral atrophy and cerebral white matter lesions in a population-based sample of middle-aged women. 15 In that study risk of temporal atrophy increased significantly and it was 13-16% per 1.0 kg/m 2 increase in BMI. Interestingly, there were no associations between BMI and atrophy measured at three other brain locations. Soreca et al. 16 studied whether current gray matter volume covaried with previously obtained longitudinal measures of weight gain among otherwise healthy postmenopausal women. Weight gain was assessed as increase in BMI. They found that premenopausal BMI and a priori chosen confounding variables explained~22% of the variance in total GMV. But 15% of the variance in total gray matter volume was uniquely explained by the change in BMI between pre-and postmenopausal longitudinal assessments. They concluded that an increase in BMI during the menopausal transition and beyond is associated with reduced gray matter volume among otherwise healthy women. Moreover, obesity was associated with reduced white matter integrity in otherwise healthy adults in studies using the diffusion tensor imaging. [17] [18] [19] Gustafson et al. 20 investigated the longitudinal relationship between BMI and white matter lesions in older women. The conclusion of the study was that overweight and obesity may be important contributors to the presence of white matter lesions in the elderly. It was found that obesity is associated with lower brain volumes in cognitively normal elderly subjects. 21 Brain atrophy was associated with obesity in demented cases also. Ho et al. 22 confirmed that, in both Alzheimer's disease and mild cognitive impairment cases, higher BMI was associated with brain volume deficits in frontal, temporal, parietal and occipital lobes. Furthermore, in the multicenter study Ewers et al. 23 tested whether lower BMI is associated with higher core AD brain pathology as assessed by cerebrospinal fluid-based biological markers of AD. They concluded that lower BMI is indicative of AD pathology as assessed with cerebrospinal fluid-based biomarkers in demented and nondemented elderly subjects.
BMI is widely accepted as a simple marker of adiposity in population-based studies. For this reason most studies use surrogate measures of adiposity such as BMI or waist circumference. But it is known that the obese phenotype is complex and can be characterized by measures of many aspects, including body fat, leg fat, liver fat and skeletal muscle mass, rather than by BMI. 24 Some authors suggest that central obesity in middle age is related to a higher risk of AD, not BMI alone. For example, Luchsinger et al. 25 examined whether measures of central obesity, waist circumference and waist to hip ratio were better predictors of AD compared with BMI in the elderly. They concluded that results of the study support the notion that central obesity is related to a higher risk of AD. The disadvantage of the simplification that BMI represents body adiposity is that BMI or waist circumference may be less valid in older populations than direct measurements of fat mass. Moreover, it is clear that BMI measurement does not provide information on body composition or distinguish between fat and fat-free mass or between visceral adipose tissue and subcutaneous abdominal fat. For example, Harris et al. 26 found that waist circumference, sagittal diameter, weight and BMI were more closely related to total body fat than to visceral fat area. They concluded that the contribution of visceral fat to health risks will be better assessed by directly measuring this fat depot. It seems that abdominal obesity to a higher degree than whole-body obesity is associated with risk of cognitive decline in late life. Furthermore, several epidemiological studies have implicated visceral fat as a major risk factor for insulin resistance, type 2 diabetes, cardiovascular disease, stroke, metabolic syndrome and death. Also, visceral fat was associated with lower brain volume in healthy middle-aged adults, but direct association between visceral adiposity and cognitive performance has not been reported. 27, 28 Yoon et al. 28 found association between high adiposity (particularly visceral adiposity) and poor cognitive functioning in younger elderly persons. Cereda et al. 29 suggested that increased visceral adipose tissue rather than BMI is a risk factor for dementia. Measurements of visceral adipose tissue (VAT) or subcutaneous adipose tissue (SAT) alone provide little information regarding the relative distribution of body fat. 30 So calculation of VAT/SAT ratio is proposed as a marker of cardiometabolic risk, above and beyond BMI and VAT. The authors of the study concluded that the propensity to store fat viscerally versus subcutaneously may be a unique risk factor independent of absolute fat volumes.
On the other hand, it is known that not only obesity, but also malnutrition causes serious consequences on almost every organ and system in the body. Malnutrition is considered a risk factor for severe complications in the course of diseases and after surgery (including death). Undernourishment increases the risk of infection, prolonged hospitalization and risk of re-hospitalization. It is well known that subclinical and overt malnutrition are strong predictive indices of morbidity and mortality in old subjects, particularly in demented ones, and may deeply affect the quality of life. Weight loss is a frequent complication of AD, associated with increased morbidity and mortality. Moreover, a BMI of o23kg/m 2 was related to reduced long-term survival in patients with various dementia diagnoses, whereas the diagnoses were not. 31 In the study by Spaccavento et al. 32 it was proved that demented patients at risk of malnutrition showed greater impairment in both simple and instrumental activities of daily living, and a more severe ideomotor praxis deficit than wellnourished patients; psychiatric symptoms showed significant differences in hallucination, apathy, aberrant motor behavior and night-time subscales of Neuropsychiatric Inventory. A low score of Mini Nutritional Assessment was a risk factor for institutional placement of elderly people with AD, but nutritional supplements applied to a group of patients with AD living in nursing homes can reduce the morbidity and mortality after 1 year follow-up. 33, 34 In the study by Magri et al., 35 the malnourished patients and demented elderly at risk for malnutrition (according to the Mini Nutritional Assessment score) were given oral nutritional supplements during hospitalization, lasting a mean of 45 days. It was proved that before discharge these two subtypes of demented patients showed substantial maintenance of their cognitive, functional and nutritional status, whereas the subgroup of well-nourished demented patients exhibited significant worsening of the nutritional pattern. The speed and severity of clinical progression after Alzheimer's disease diagnosis varies and depends on multiple factors, most not well elucidated. Vellas et al. 36 have found that undernourished patients seem to present more rapid aggravation of the disease, but, paradoxically, these patients appear to be those who best respond to treatment with cholinesterase inhibitors.
Studies on the influence of specific types of diet and physical activity on the risk of, course and modification of clinical picture of Alzheimer's disease were carried out. 37 It was proved that both higher Mediterranean-type diet adherence and higher physical activity were independently associated with reduced risk for AD. 38 Many of the dietary interventions (food supplements, fatty acids) and professional diets were examined as preventing factors or the treatment of early-stage dementia. The results of research in this area are inconclusive. It seems too early to recommend any dietary intervention as a standard procedure in Alzheimer's dementia. The same situation exists in prevention of the cognitive decline, although the results of some projects seem to be encouraging. 39 
NUTRITION AND DEMENTIA PROJECT (NUTRDEM PROJECT)
Most of the studies in the field of nutrition and cognition were carried out within populations other than the Polish population and relate to an entirely different kind of diet and dietary patterns than are practiced in Poland. Thus, it seems to be extremely valuable to start the research in this field. Research aimed at identifying mechanisms that underlie the associations between diet, nutrition and components of metabolic syndrome, and cognitive decline is expected.
The Department of Old Age Psychiatry and Psychotic Disorders was started in collaboration with the Department of Medical Psychology on Nutrition and Dementia Project (NutrDem Project).
The aim of the study is to determine the effect of dietary patterns, nutritional status, body composition (with evaluation of visceral fat) and basic regulatory mechanisms of metabolism in elderly patients on cognitive functions and the risk of cognitive impairment (mild cognitive impairment and/or dementia).
Our first hypothesis is that the dietary patterns and diets used and the nutritional status have an impact on cognitive performance and may be a risk factor for cognitive impairment. Secondly, it was assumed that the assessment of body composition, especially the measurement of visceral fat, may help in assessing the risk of cognitive impairment. Finally, it was assumed that the change in nutritional status and in body composition may indicate a dysregulation of the fundamental mechanisms that regulate metabolism and may be a harbinger of dementia.
In order to verify our hypotheses, the use of several specialized clinical and laboratory tests is planned. Type of dietary patterns and eating habits, risk of malnutrition, body composition and nutritional status will be evaluated. Numerous biochemical blood parameters will be measured, including detailed lipid profile, fasting plasma glucose, electrolytes, albumin, insulin, hemoglobin A1c, levels of homocysteine, vitamin D, folic acid and vitamin B12, vitamin D, prolactin, transferrin, ferritin, and markers of inflammation. Quantitative measurements of neuropeptides that regulate energy homeostasis at the central level (neuropeptide-Y, cocaineand amphetamine-regulated transcript protein, agouti-related protein and others) and at the peripheral level (leptin, ghrelin and others) will be done. Clinical tests comprising a psychiatric examination and an assessment of cognitive functions (the neuropsychological testing with CANTABeclipse computer test battery) will be conducted parallely to laboratory measurements. More details on the design of the project can be found in Figure 1 .
Thinking about a reliable assessment of nutritional status and precise insight into the basic metabolic processes of the body has changed definitely with the introduction of measurement methods that permit an analysis of the body composition, as opposed to the previously used anthropometric methods (waist circumference, skin folds or BMI calculation). Novel approaches to evaluate body composition have been developed in the recent years, including the use of bioelectrical impedance analysis and dual-energy X-ray absorptiometry. Both techniques are promising and cheaper than imaging techniques (such as computed tomography or magnetic resonance imaging). Both techniques, bioelectrical impedance analysis and dual-energy X-ray absorptiometry, not only enable more precise measures of body composition but also have been found to be more reliable as compared to standard methods in several clinical contexts, including obesity, diabetes, hypertension, dyslipidemia, metabolic syndrome, chronic renal failure, surgery and wasting syndromes (HIV/AIDS) patients' care. To our knowledge, relevant observations in the elderly in general and the demented in particular are limited. Furthermore, only a limited number of iDXA scanners with CoreScan are present in Poland. So far, in Polish research centers such precise and inexpensive assessment of body composition was not possible. Influence of body composition on cognition
